# Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes

> **NCT06715514** · NA · RECRUITING · sponsor: **Lia Bally** · enrollment: 96 (estimated)

## Conditions studied

- Menopause
- Type 2 Diabetes

## Interventions

- **DRUG:** GLP-1 Receptor Agonist
- **DRUG:** Menopausal Hormone Therapy

## Key facts

- **NCT ID:** NCT06715514
- **Lead sponsor:** Lia Bally
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-18
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06715514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06715514, "Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06715514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*